introduced relevant changes in the management of the harvest of haemopoietic cells by cytapheresis.
Mean number of CD34-expressing cells (multiple determinations) b dard deviation and consequently the coefficient of variation were calculated. At one site, more detailed experimental work was done. Thirty randomly selected samples sent for diagnostic determinations of CD34-expressing cells were processed. Samples were stained with CD45-monoclonal antibody (MoAb) coupled to FITC and with class III CD34-MoAb coupled to PE (both MoAbs from Coulter-Immunotech, Marseille, France). Samples were stained, subjected to red blood cell lysis with ammonium chloride (Ortho, Raritan, NJ, USA), centrifuged twice, and finally resuspended in phosphate-buffer with subsequent flow cytometry on a FACScan (BDIS, Mountain View, CA, USA). The method has been described in detail. 10 Two different approaches with regard to quantitation of CD34-expressing cells were compared. First, the approach routinely followed in this institution: 3 × determinations of 50 000 total cells per determinations, and thus with an unknown number of CD34-expressing cells; second, 3 × determinations with an In view of the non-Gaussian distribution of the para- The coefficient of variation in CFU-GM counting averaged CD34-expressing cells triplicates (38 samples), quadrupli-31%. This coefficient of variation in routine-determinations cates (18 samples), five replicates (seven samples), six repcompares only slightly unfavourably with the coefficient of licates (24 samples), seven replicates (13 samples); at instivariation of 25% as determined from tables showing inditution C, duplicate dishes for CFU-GM colonies and vidual CFU-GM colony-numbers in six randomly selected triplicates for CD34-expressing cells; at institution D, triplipublications 11-16 focusing on CFU-GM colonies in a fully cate dishes for CFU-GM colonies and duplicates for CD34-experimental setting. In contrast, with data available from expressing cells; at institution E, for CFU-GM colonies four institutions, the coefficient of variation in counting duplicate dishes (seven samples), triplicate dishes (195 CD34-expressing cells by flow cytometry averaged 10% samples), quadruplicate dishes (243 samples); at institution (Table 1) . F, for CFU-GM colonies, duplicate dishes.
Correlating the coefficient of variation of each method For each single sample, the mean number and the stanto the counting events per single sample, it was realized that there is a threshold value of counting events associated with an acceptable degree of imprecision, eg with a coefficient of variation of about 15%. Figure 1 shows the pooled of CD34-expressing cells in each given sample. Having substantial differences in the precision of the two laboratory tests. This imprecision in counting CFU-GM colonies averlearned that the coefficient of variation in counting CD34-expressing cells dropped to an average of 15% when at aged 31%, in contrast to an average imprecision of only 10% in counting CD34-expressing cells. These data are not least 250 CD34-expressing cells were detected in one single determination, the second counting method consisted of just of methodological interest since they may explain in part the observed relationships between progenitor cells determinations including a fixed number of 250 CD34-expressing cells per single determination. This approach transplanted and engraftment time. There is widespread agreement that there are threshold doses of progenitor cells results in largely differing numbers of total cells per determination (Table 2 ). Figure 2 shows the clear-cut depenfor rapid haematological engraftment. [18] [19] [20] [21] [22] [23] Above these thresholds engraftment is nearly always rapid but below dence of the coefficient of variation in counting CD34-expressing cells from the relative numbers of CD34-the 'threshold dose' there is great variability: some patients recover promptly and in others engraftment, especially of expressing cells in the sample. In contrast, it is also shown that making determinations with the fixed number of 250 platelets, is greatly prolonged. The data presented here suggest that some of this variability may be due to inaccuracies CD34-expressing cells per single determination, the imprecision is significantly lower, and it is also almost constant.
in the progenitor cell measurements with the 'true threshold dose' estimated to be lower than usually cited. This may be particularly true for CFU-GM measurements which many 9, [19] [20] [21] [22] although not all 23 centres find less satisfactory Discussion than measurements of CD34-expressing cells for establishing cellular threshold doses. An in vitro test that adequately assesses the short-and longterm repopulating haemopoietic cell in vivo is not available Our data provide a base for the critical appraisal of both routine laboratory methods for assessment of haemopoietic for human haemopoietic cell therapy. Therefore, in routine clinical practice, two surrogate tests which tentatively grafts. With regard to the counting statistics, there is no way to minimize the imprecision in CFU-GM colony counassess the haemopoietic potential of the haemopoietic graft are used, the CFU-GM colony test performed by in vitro ting. In contrast, the measurements of CD34-expressing cells can be optimised, basing these flow cytometric deterculture and the flow cytometric assay of CD34-expressing cells. These tests are often referred to as measures of some minations on a statistically significant fixed number of CD34-expressing cells. Last but not least, the large differkind of 'quality-control'. 17 The data presented here show 
